Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placenta-derived stem cell bandage for diabetic chronic wound healing
IRCT20191007045008N2Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of placenta-derived mesenchymal stem cells in diabetes mellitus (DM) and Chronic wound (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Wound closure rate, Tissue regeneration and 2 more. Started Sep 2023; status: completed.
02
Drugs
placenta-derived mesenchymal stem cells
03
Conditions
diabetes mellitus (DM)Chronic wound
Beyond the preview
Go deeper on IRCT20191007045008N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191007045008N2.